Unlike cisplatin, no correlation was observed between the cytotoxic effect and HNRNPU expression level in the six bladder cancer cell lines, suggesting that HNRNPU mainly mediates the response of bladder cancer cells to cisplatin. This evidence concerns the gene HNRNPU and urinary bladder carcinoma.